Column GROUP Iii-a, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 15 shares at $12.00 ($180) on 2019-11-11, disclosed to the SEC on 2019-11-13.
Open-market purchase of $180 NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| SRZN | BUY | 2024-04-17 | $6.0M | — | Filing → |
| TNYA | BUY | 2024-02-14 | $10.0M | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |